Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions

Radiotherapy and Oncology

Volumn 94, Issue 3, 2010, Pages 280-285

  van der Laan, Hans Paul ^a   Hurkmans, Coen W ^b   Kuten, Abraham ^c   Westenberg, Helen A ^d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d Institute for Radiation Oncology Arnhem   (Netherlands)

Author keywords

Breast radiotherapy; Clinical practice; EORTC; Radiotherapy technique; Survey

Indexed keywords

ARTICLE; BREATH HOLDING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON RADIATION; INTENSITY MODULATED RADIATION THERAPY; MEDICAL TECHNOLOGY; PHOTON THERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOTHERAPY; RISK FACTOR; TREATMENT PLANNING;

BREAST NEOPLASMS; EUROPE; FEMALE; HEALTH SURVEYS; HISTORY, 21ST CENTURY; HUMANS; QUESTIONNAIRES; RADIATION DOSAGE; SOCIETIES, MEDICAL;

EID: 77949278806     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.12.032     Document Type: Article

References (41)

1. Agren Cronqvist A.K., Kallman P., Turesson I., et al. Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours. Acta Oncol 34 (1995) 851-860
2. Poortmans P.M., Venselaar J.L., Struikmans H., et al. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I-III breast cancer. Int J Radiat Oncol Biol Phys 49 (2001) 1399-1408
3. Peters L, O'Sullivan B, Girald J, et al. Critical impact of radiotherapy protocol compliance and plan quality in treatment of advanced head and neck cancer (Abstr.). In: Second ICHNO conference abstract book; 2009. p. s6.
4. Delaney G., Blakey D., Drummond R., et al. Breast radiotherapy: an Australasian survey of current treatment techniques. Australas Radiol 45 (2001) 170-178
5. Winfield E., Deighton A., Venables K., et al. Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer. Clin Oncol (R Coll Radiol) 14 (2002) 267-271
6. Jalali R., Singh S., and Budrukkar A. Techniques of tumour bed boost irradiation in breast conserving therapy: current evidence and suggested guidelines. Acta Oncol 46 (2007) 879-892
7. Vu T.T., Pignol J.P., Rakovitch E., et al. Variability in radiation oncologists' opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey. Clin Oncol (R Coll Radiol) 19 (2007) 115-119
8. Thomsen M.S., Berg M., Nielsen H.M., et al. Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group. Acta Oncol 47 (2008) 654-661
9. Morgia M., Lamoury G., and Morgan G. Survey of radiotherapy planning and treatment of the supraclavicular fossa in breast cancer. J Med Imaging Radiat Oncol 53 (2009) 207-211
10. Drummond R., Power A., Evans A., et al. Changes in practice of breast cancer radiotherapy 1998-2002: an Australasian survey. Australas Radiol 49 (2005) 44-52
11. Hurkmans C.W., Meijer G.J., van Vliet-Vroegindeweij C., et al. High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys 66 (2006) 923-930
12. van der Laan H.P., Dolsma W.V., Maduro J.H., et al. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1018-1023
13. Hurkmans C.W., Borger J.H., Bos L.J., et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 55 (2000) 145-151
14. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371 (2008) 1098-1107
15. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9 (2008) 331-341
16. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
17. Whelan T.J., Pignol J., Julian J., et al. Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancer (Abstract). Int J Radiat Oncol Biol Phys 18 (2008) S28
18. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
19. Joiner M.C., and van der Kogel A.J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel G.G. (Ed). Basic clinical radiobiology. 2nd ed. (1997), Arnold, London
20. Yang T.I., Elkhuizen P.H., Minkema D., et al. Clinical factors associated with seroma volume reduction in breast-conserving therapy for early-stage breast cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys (2009) 10.1016/j.ijrobp.2009.03.056
21. McDonald M.W., Godette K.D., Whitaker D.J., et al. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost. Int J Radiat Oncol Biol Phys (2009) 10.1016/j.ijrobp.2009.05.042
22. Veness M.J., and Delaney G. Variations in breast tangent radiotherapy: a survey of practice in New South Wales and the Australian Capital Territory. Australas Radiol 43 (1999) 334-338
23. Pignol J.P., Olivotto I., Rakovitch E., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26 (2008) 2085-2092
24. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82 (2007) 254-264
25. Harsolia A., Kestin L., Grills I., et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1375-1380
26. Vicini F., Beitsch P.D., Quiet C.A., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112 (2008) 758-766
27. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
28. Benda R.K., Yasuda G., Sethi A., et al. Breast boost: are we missing the target?. Cancer 97 (2003) 905-909
29. Poortmans P., Bartelink H., Horiot J.C., et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. Radiother Oncol 72 (2004) 25-33
30. Hurkmans C.W., Borger J.H., Pieters B.R., et al. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 50 (2001) 1366-1372
31. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
32. Faverly D.R., Hendriks J.H., and Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 91 (2001) 647-659
33. Stroom J., Schlief A., Alderliesten T., et al. Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy. Int J Radiat Oncol Biol Phys 74 (2009) 898-905
34. Jones H.A., Antonini N., Hart A.A., et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol 27 (2009) 4939-4947
35. van der Laan H.P., Dolsma W.V., Maduro J.H., et al. Dosimetric consequences of the shift towards computed tomography guided target definition, planning for breast conserving radiotherapy. Radiat Oncol 3 (2008) 6
36. Uwini S.A., Antonini N., Poortmans P.M., et al. The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment. Radiother Oncol 93 (2009) 87-93
37. Hurkmans C., Admiraal M., van der Sangen M., et al. Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. Radiother Oncol 90 (2009) 60-65
38. Hooning M.J., Botma A., Aleman B.M., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99 (2007) 365-375
39. van der Laan H.P., Dolsma W.V., Van't Veld A.A., et al. Comparison of normal tissue dose with three-dimensional conformal techniques for breast cancer irradiation including the internal mammary nodes. Int J Radiat Oncol Biol Phys 63 (2005) 1522-1530
40. Chino J.P. Marks LB Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int J Radiat Oncol Biol Phys 70 (2008) 916-920
41. Giro C., Berger B., Bolke E., et al. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiother Oncol 90 (2009) 166-171